[
  {
    "ts": "2025-09-11T16:24:00+00:00",
    "headline": "Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study",
    "summary": "PLSE wins FDA IDE approval for its NANOCLAMP AF study, advancing nsPFA tech as a novel option in atrial fibrillation surgery.",
    "url": "https://finance.yahoo.com/news/pulse-biosciences-gets-fda-ide-162400072.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "dd7c84b5-ccb9-3c10-a55e-d62586e1a691",
      "content": {
        "id": "dd7c84b5-ccb9-3c10-a55e-d62586e1a691",
        "contentType": "STORY",
        "title": "Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study",
        "description": "",
        "summary": "PLSE wins FDA IDE approval for its NANOCLAMP AF study, advancing nsPFA tech as a novel option in atrial fibrillation surgery.",
        "pubDate": "2025-09-11T16:24:00Z",
        "displayTime": "2025-09-11T16:24:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ae98f9f4477af1de31a0a61cde692d41",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OFzi8.fflc0QvY_fkj9xyQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ae98f9f4477af1de31a0a61cde692d41.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XEcGARCYysPADgwWqEzSbg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ae98f9f4477af1de31a0a61cde692d41.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pulse-biosciences-gets-fda-ide-162400072.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pulse-biosciences-gets-fda-ide-162400072.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVST"
            },
            {
              "symbol": "WST"
            },
            {
              "symbol": "PLSE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-11T16:20:00+00:00",
    "headline": "Here's Why You Should Retain OPKO Health Stock in Your Portfolio",
    "summary": "OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.",
    "url": "https://finance.yahoo.com/news/heres-why-retain-opko-health-162000210.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "2e5c298e-9053-30a3-a4e4-790dda401348",
      "content": {
        "id": "2e5c298e-9053-30a3-a4e4-790dda401348",
        "contentType": "STORY",
        "title": "Here's Why You Should Retain OPKO Health Stock in Your Portfolio",
        "description": "",
        "summary": "OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.",
        "pubDate": "2025-09-11T16:20:00Z",
        "displayTime": "2025-09-11T16:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZwoKmvWtG4m50IBSf0NKDQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LkiDNdOPbO2HoLFk.M.nKA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-retain-opko-health-162000210.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-retain-opko-health-162000210.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVST"
            },
            {
              "symbol": "WST"
            },
            {
              "symbol": "OPK"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-11T12:24:00+00:00",
    "headline": "Reasons to Add West Pharmaceutical Stock to Your Portfolio Now",
    "summary": "WST rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.",
    "url": "https://finance.yahoo.com/news/reasons-add-west-pharmaceutical-stock-122400033.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c09d2dbf-9e7c-3f83-bb62-26ba8c7df673",
      "content": {
        "id": "c09d2dbf-9e7c-3f83-bb62-26ba8c7df673",
        "contentType": "STORY",
        "title": "Reasons to Add West Pharmaceutical Stock to Your Portfolio Now",
        "description": "",
        "summary": "WST rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.",
        "pubDate": "2025-09-11T12:24:00Z",
        "displayTime": "2025-09-11T12:24:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d7sHwZPFV1U3B4BGoNlXfg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k5CBlnqEqKxZI1S0BuG_ug--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/reasons-add-west-pharmaceutical-stock-122400033.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/reasons-add-west-pharmaceutical-stock-122400033.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WST"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]